Envarsus

Veloxis Pharmaceuticals, Inc🇺🇸 United States

FDA Page

Effective Date: Sep 26, 2023
Approval ID: de2315b0-6344-43ac-9aea-3e3b68d828e7
Products: 3 registered
Version: 14

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ENVARSUS XR safely and effectively. See full prescribing information for ENVARSUS XR. ENVARSUS XR (tacrolimus extended-release tablets), for oral use Initial U.S. Approval: 1994

Quick Stats

Total Products3

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.